Overview

Codeine in Sickle Cell Disease

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to determine if a subject's genetic make-up would affect the treatment response to codeine in subjects with sickle cell disease.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

PriCara, Unit of Ortho-McNeil, Inc.

Treatments:

Codeine